Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 4160 of 20,252 grants

Active NON-SBIR/STTR RPGS
Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT Our team’s long-term goal is to promote the health and well-being of “metavivors,” a growing population of individuals living long-term with metastatic can...

$3.19M
USD
Active NON-SBIR/STTR RPGS
Determine the Role of Histone Methyltransferase ASH1L in Metastatic Prostate Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

Metastasis is the major cause of cancer mortality. Effective therapies are urgently needed for patients with metastatic diseases. Increasing evidence suggests that interactions bet...

$5.38M
USD
Active NON-SBIR/STTR RPGS
Circulating metabolites as novel risk biomarkers for gastric cancer: a large multi-center prospective investigation
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

ABSTRACT Gastric cancer is one of the most common and deadly cancers globally, accounting for over one million new cancer diagnoses and 783,000 deaths in 2018. Infection of Helicob...

$7.65M
USD
Active NON-SBIR/STTR RPGS
Uncovering Causal Protein Markers to Characterize Pancreatic Cancer Etiology and Improve Risk Prediction
NATIONAL CANCER INSTITUTE University of Hawaii At Manoa United States 2024 – 2029

Pancreatic cancer (PC) is the third leading cause of cancer mortality in the United States. The vast majority of PC are pancreatic ductal adenocarcinoma (PDAC). The etiology of PDA...

$7.37M
USD
Active NON-SBIR/STTR RPGS
Distance-based Exercise to preserve Function and prevENt Disability (DEFEND)
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2027

PROJECT SUMMARY Many cancer survivors experience challenges in performing daily activities and loss of work productivity due to the adverse effects of cancer and its treatments, re...

$2.95M
USD
Active NON-SBIR/STTR RPGS
Partners in Research: Building capacity for community-driven research to advance health equity
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

ABSTRACT Structural factors of health inequities are the systemic and societal conditions that contribute to disparities in health among different populations. These disparities of...

$7.49M
USD
Active NON-SBIR/STTR RPGS
Cultivating programmatic efforts to optimize the conduct and implementation of NCI-funded clinical trials
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2024 – 2029

Dr. Cathy Eng is an exemplary Clinician Scientist who, throughout her career, has held numerous roles within the National Clinical Trials Network (NCTN) and is viewed, by her peers...

$1.3M
USD
Active NON-SBIR/STTR RPGS
Comprehensive Analysis and Multi-Omics Data Integration for Cancer-Related Studies
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2029

Project Summary/Abstract I am a principal data scientist and bioinformatics manager of The Experimental and Computational Genomics Core in the Sidney Kimmel Comprehensive Cancer Ce...

$1.57M
USD
Active NON-SBIR/STTR RPGS
POINT of CARE: PrOviding an Innovative New Triage and Treatment strategy for Cervical cAncer scReening Efficiency
NATIONAL CANCER INSTITUTE Basic Health International, Inc United States 2024 – 2029

PROJECT SUMMARY Although preventable, cervical cancer is a leading cause of mortality in low- and middle-income countries (LMIC). Infection with high-risk human papillomavirus (HPV...

$4.81M
USD
Active NON-SBIR/STTR RPGS
Novel Statistical Models for Intensive Longitudinal Analyses of Cancer Control Behaviors
NATIONAL CANCER INSTITUTE University of Chicago United States 2024 – 2028

PROJECT SUMMARY This project will develop, test, apply, and disseminate multilevel statistical models and software for estimating effects of intraindividual means, variances, slope...

$6.5M
USD
Active NON-SBIR/STTR RPGS
Advancing breast cancer risk assessment for Black women
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2029

ABSTRACT Effective treatment schemes have reduced breast cancer mortality, but precise identification of women at increased risk of developing breast cancer, to personalize screeni...

$6.45M
USD
Active NON-SBIR/STTR RPGS
Myeloma multidimensional precancer atlas
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

SUMMARY Multiple Myeloma (MM) is almost always preceded by monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM), with a transformation rate of ~1%...

$11.29M
USD
Active SBIR-STTR RPGS
Development of a lung cancer subtyping diagnostic
NATIONAL CANCER INSTITUTE Orbit Genomics, Inc United States 2024 – 2026

DEVELOPMENT OF A LUNG-CANCER SUBTYPING DIAGNOSTIC Abstract The overall goal of the proposed project will be to create a high sensitivity, high specificity subtyping test for lung c...

$10M
USD
Active NON-SBIR/STTR RPGS
Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol use among PWH in Nairobi, Kenya
NATIONAL CANCER INSTITUTE University of Chicago United States 2024 – 2029

Project Summary. Sub-Saharan Africa is home to >70% of people with HIV (PWH) globally. It is also burdened with rising rates of tobacco use, high rates of unhealthy alcohol use,...

$7.28M
USD
Active SBIR-STTR RPGS
Development of an antibody-oligonucleotide conjugate for treatment of Head and Neck Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE Mirecule, Inc United States 2024 – 2026

Abstract: In this Direct to Phase II SBIR application, miRecule proposes to develop MC-30 an Antibody RNA Conjugate (ARC), composed of the anti-EGFR antibody cetuximab conjugated t...

$8.64M
USD
Completed SBIR-STTR RPGS
Advancing Next Generation CAR-T cells for Renal Cell Carcinoma
NATIONAL CANCER INSTITUTE Cellinfinity Bio, Inc United States 2024 – 2025

Project Summary/Abstract Renal Cell Carcinoma (RCC) accounts for approximately 90% of kidney cancers in adults. Despite the advancements made in cytokine, immune checkpoint, and ta...

$4M
USD
Active SBIR-STTR RPGS
In vivo efficacy, safety and PK/PD analysis of SYN101, a first in class, immune cell targeted TGFb therapy for cancer patients
NATIONAL CANCER INSTITUTE Synthis Therapeutics, Inc United States 2024 – 2026

NCI SBIR Phase II Summary The immune checkpoint inhibitors (ICI) block a single immuno-suppressive pathway in cancer patients. However, across all cancers, less than 30% of patient...

$5.79M
USD
Active NON-SBIR/STTR RPGS
Using gene expression to identify patients at high risk for late breast cancer recurrence
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2024 – 2029

PROJECT SUMMARY Non-metastatic breast cancer is treated surgically and with adjuvant therapies. As these treatments have improved, recurrence-free survival has steadily increased,...

$5.95M
USD
Completed SBIR-STTR RPGS
Preventing chemotherapy-related toxicities and infections with a novel phosphorylated triblock copolymer
NATIONAL CANCER INSTITUTE Covira Surgical United States 2024 – 2025

PROJECT SUMMARY Covira Surgical, Inc. is developing a first-in-class agent for preventing chemotherapy-related gastrointestinal (GI) toxicities and lethal infections. Chemotherapy...

$4M
USD
Active NON-SBIR/STTR RPGS
Personalized Cancer Support for Young Adults
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2027

PROJECT SUMMARY Worry and distress in cancer survivors are common, do not correlate with disease severity, and are heightened in young adults who are going through multiple life tr...

$2.9M
USD